−2.4940USD
−97.16 MUSD
770.00 KUSD
34.64 M
About Atreca, Inc.
Sector
Industry
CEO
John A. Orwin
Website
Headquarters
San Carlos
Employees (FY)
90
Founded
2010
ISIN
US04965G1094
FIGI
BBG00P96JT34
Atreca, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing novel antibody-based therapeutics to treat a range of solid tumor types. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response. The company was founded by Robert Axtell, Guy Cavet, Jeremy Sokolove, Tito A. Serafini, Paulette A. Dillon, Daniel Emerling, Wayne Volkmuth, Jonathan Woo, Yann Chong Tan, William H. Robinson and Lawrence J. Steinman on June 11, 2010 and is headquartered in San Carlos, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BCEL is 0.0770 USD — it has increased by 1.18% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Atreca, Inc. stocks are traded under the ticker BCEL.
Atreca, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
BCEL stock is 11.84% volatile and has beta coefficient of 4.83. Check out the list of the most volatile stocks — is Atreca, Inc. there?
BCEL earnings for the last quarter are −0.92 USD per share, whereas the estimation was −0.38 USD resulting in a −144.87% surprise. The estimated earnings for the next quarter are −0.35 USD per share. See more details about Atreca, Inc. earnings.
Atreca, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach 216.67 K USD.
Yes, you can track Atreca, Inc. financials in yearly and quarterly reports right on TradingView.
BCEL stock has risen by 2.26% compared to the previous week, the month change is a 10.00% rise, over the last year Atreca, Inc. has showed a 91.98% decrease.
BCEL net income for the last quarter is −36.22 M USD, while the quarter before that showed −19.19 M USD of net income which accounts for −88.76% change. Track more Atreca, Inc. financial stats to get the full picture.
Today Atreca, Inc. has the market capitalization of 3.02 M, it has increased by 8.03% over the last week.
No, BCEL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BCEL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Atreca, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 90.00 employees. See our rating of the largest employees — is Atreca, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Atreca, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Atreca, Inc. stock shows the sell signal. See more of Atreca, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Atreca, Inc. EBITDA is −71.49 M USD, and current EBITDA margin is −11.75 K%. See more stats in Atreca, Inc. financial statements.